Cargando…
Oncogenic Role of HMGB1 as An Alarming in Robust Prediction of Immunotherapy Response in Colorectal Cancer
SIMPLE SUMMARY: The high mobility group box1 (HMGB1) protein operates as an alarm for danger. We explore the correlation between HMGB1 expression and the clinical survival status of patients receiving antitumor immunotherapy toward assessing the prognostic value in a multicancer context. We further...
Autores principales: | Lu, Huijiao, Zhu, Mengyi, Qu, Lin, Shao, Hongwei, Zhang, Rongxin, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563811/ https://www.ncbi.nlm.nih.gov/pubmed/36230798 http://dx.doi.org/10.3390/cancers14194875 |
Ejemplares similares
-
A Novel Oncogenic Role of FDX1 in Human Melanoma Related to PD-L1 Immune Checkpoint
por: Lu, Huijiao, et al.
Publicado: (2023) -
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
por: Zhu, Gongmin, et al.
Publicado: (2021) -
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
por: Liikanen, Ilkka, et al.
Publicado: (2015) -
Global Pattern of CD8(+) T-Cell Infiltration and Exhaustion in Colorectal Cancer Predicts Cancer Immunotherapy Response
por: Tian, Sun, et al.
Publicado: (2021) -
Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis
por: Wang, Chao-Qun, et al.
Publicado: (2020)